SelectImmune Pharma is a pharmaceutical company. The company intends to develop drug candidates with focus on endogenous inflammatory agents and bacterial molecules. The products are aimed at strengthening the immune system and are mainly used for the treatment of infectious diseases, as well as chronic inflammation. The company was founded in 2017 and has the largest operations in the Nordic market.

Quotes for SelectImmune Pharma AB (publ)

Right Now

+/-
1
%
6,41%
Latest
16.6
High
16.95
Low
14.8
Volume
35 788
Turnover (SEK)
574 623
Value (MSEK)
260,1

Board

CEO

  • Fredrik Herslow

Chairman Of The Board

  • Catharina Svanborg

Board

  • Björn Kettilsson Wullt
  • Carl-Johan Wachtmeister
  • Helena Lomberg

Largest Owners

Name Capital % Votes % Date
Catharina Svanborg 43,43 71,98 2019-07-10
FV Group AB 7,15 3,33 2019-06-30
Nordnet Pensionsförsäkring 6,89 3,21 2019-06-30
Fredrik Herslow 4,40 2,05 2019-06-30
Jan Zetterberg 3,62 1,68 2019-06-30
Understödsföreningen Prometheus Pension 3,62 1,68 2019-06-30
Avanza Pension 3,26 1,52 2019-06-30
Helena Lomberg 1,70 0,79 2019-06-26
Johan Thorell 1,39 0,65 2019-06-30
John Fällström 1,09 0,51 2019-06-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2019-08-29 Bokslutskommuniké 2019

  • 2019-11-07 Delårsrapport 2020-Q1

  • 2019-11-20 Årsstämma 2019

Annual reports, prospectus etc.